Successful Treatment Of Acquired Hemophilia A Using FEIBA Supplemented With Emicizumab

被引：0
|
作者：
Nazish Kaunchale
Shahana Ansari
Apurva More
Shweta Bansal
Shrinath Kshirsagar
Balkrishna Padate
Savita Rangarajan
Shrimati Shetty
机构：
[1] K.J.Somaiya Hospital and Research Centre,
[2] Somaiya Ayurvihar,undefined
[3] Sion ( East),undefined
[4] P.D.Hinduja National Hospital & Medical Research Centre,undefined
来源：
Indian Journal of Hematology and Blood Transfusion | 2023年 / 39卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：159 / 160
页数：1
相关论文
共 50 条
  • [21] Emicizumab versus immunosuppressive therapy for the management of acquired hemophilia A
    Hart, Christina
    Klamroth, Robert
    Sachs, Ulrich J.
    Greil, Richard
    Knoebl, Paul
    Oldenburg, Johannes
    Miesbach, Wolfgang
    Pfrepper, Christian
    Trautmann-Grill, Karolin
    Pekrul, Isabell
    Holstein, Katharina
    Eichler, Hermann
    Weigt, Carmen
    Schipp, Dorothea
    Werwitzke, Sonja
    Tiede, Andreas
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2024, 22 (10) : 2692 - 2701
  • [22] EMICIZUMAB TREATMENT IN PATIENT WITH ACQUIRED HEMOPHILIA CAN BE A RELAY TO BYPASSING AGENTS: A CASE REPORT
    Toutain, I. Martin
    Launois, A.
    Lambert, J.
    Longval, T.
    Merabet, F.
    Jaidi, R.
    LeDore, S.
    Ferre, E.
    De Raucourt, E.
    Flaujac, C.
    HAEMOPHILIA, 2023, 29 : 98 - 98
  • [23] Clinical pharmacology of emicizumab for the treatment of hemophilia A
    Yoneyama, Koichiro
    Schmitt, Christophe
    Portron, Agnes
    Kiialainen, Anna
    Kotani, Naoki
    Jaminion, Felix
    Retout, Sylvie
    Adamkewicz, Joanne, I
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2023, : 775 - 790
  • [24] Successful Treatment with Emicizumab of Patient with Type 2N Normandy and Severe Hemophilia a
    Bryant, Paulette
    Lineberger, Elizabeth
    Carr, Courtney Huckel
    Kaus, Angela
    BLOOD, 2021, 138
  • [25] Emicizumab for acquired hemophilia A: Report of two cases and dosing strategies
    Ahmed, Faiza
    Kasianchyk, Mariia
    Moreno, Alejandro
    Chang, Simone
    Maharaj, Satish
    EJHAEM, 2024, 5 (02): : 387 - 391
  • [26] Successful use of emicizumab in a patient with refractory acquired hemophilia A and acute coronary syndrome requiring percutaneous coronary intervention
    Dane, Kathryn E.
    Lindsley, John P.
    Streiff, Michael B.
    Moliterno, Alison R.
    Khalid, Mian K.
    Shanbhag, Satish
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2019, 3 (03) : 420 - 423
  • [27] Acquired hemophilia A: a narrative review and management approach in the emicizumab era
    Ellsworth, Patrick
    Chen, Sheh-Li
    Jones, Lee Ann
    Ma, Alice D.
    Key, Nigel S.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2025, 23 (03) : 824 - 835
  • [28] Successful treatment of acquired hemophilia A, complicated by chronic GVHD, with tocilizumab
    Nishida, Sumiyuki
    Kawasaki, Tomio
    Kashiwagi, Hirokazu
    Morishima, Atsuyoshi
    Hishitani, Yoshihiro
    Kawai, Mari
    Hirano, Toru
    Ishii, Taeko
    Hagihara, Keisuke
    Shima, Yoshihito
    Narazaki, Masashi
    Ogata, Atsushi
    Oka, Yoshihiro
    Kishimoto, Tadamitsu
    Tanaka, Toshio
    MODERN RHEUMATOLOGY, 2011, 21 (04) : 420 - 422
  • [29] SUCCESSFUL TREATMENT WITH ELIMINATING THE INHIBITOR OF ACQUIRED HEMOPHILIA A; CASE REPORT
    Durusoy, S. S.
    Akkurd, D. M.
    Sahin, H. H.
    Savas, T.
    Buyukbebeci, O.
    Okan, V.
    HAEMOPHILIA, 2020, 26 : 128 - 128
  • [30] Emicizumab for the Treatment of Acquired Hemophilia_A: Lessons Learned from 4 Very Different Cases
    Knoebl, Paul
    Sperr, Wolfgang R.
    Schellongowski, Peter
    Staudinger, Thomas
    Jilma-Stohlawetz, Petra
    Quehenberger, Peter
    Koder, Silvia
    Ay, Cihan
    Gleixner, Karoline V.
    BLOOD, 2018, 132
12345